ILXQuant GLP-1 Drug Supply Chain Infrastructure Basket Index
Fixed-basket index of 10 companies providing the physical supply chain layer underneath the GLP-1 obesity drug revolution -- the glass, rubber, steel, and precision engineering that makes every injection possible. West Pharmaceutical Services makes the rubber stoppers and plungers for every injectable drug in the world -- there are exactly two companies at the required purity grade and West has 90-plus percent renewal rates. Gerresheimer AG makes the glass vials and pen cartridges for Novo Nordisk and Lilly GLP-1 devices; Novo Nordisk paid Gerresheimer EUR 500M upfront in 2024 just to secure capacity. Becton Dickinson makes the auto-injector systems. STERIS validates and sterilises the manufacturing environment. ICON and IQVIA run the clinical trials. Natera provides metabolic disease diagnostics. ResMed pivots from sleep apnea to metabolic health monitoring. Regeneron and Amphastar round out the pharmaceutical platform layer. Rebalances quarterly to equal weight.
- Index identifier
- ILXINJ
- Category
- Basket
- Universe
- Fixed basket -- 10 GLP-1 drug supply chain infrastructure companies (equal weight)
- Currency
- USD
- Inception
- 2021-03-01
- Rebalancing
- Quarterly (first Monday of March, June, September, December)
- Index fee
- 0.60% p.a.
- Reference benchmark
- Health Care SPDR (XLV)
Performance and risk
All figures below are measured over a trailing window of up to 1,260 trading days (approximately five years), not since index inception.
| Annualised return | +5.66% |
|---|---|
| Sharpe ratio | 0.25 |
| Calmar ratio | 0.18 |
| Volatility | 22.25% |
| Maximum drawdown | -31.02% |
| Return, 1 month | — |
| Return, 3 months | — |
| Return, 1 year | — |
| Return, year to date | +4.49% |
Full performance history, drawdown analysis, rolling risk metrics and portfolio breakdowns for this index are available in the ILX Quant platform.